Vland Biotech(SH:603739)2021-10-28 16:00Key Financial Data Summary This section summarizes the company's robust financial performance and significant balance sheet changes for the first three quarters of 2021 Key Accounting Data and Financial Indicators The company achieved robust growth in the first three quarters of 2021, with operating revenue increasing by 20.20% and net profit attributable to parent company shareholders by 29.34% Key Financial Indicators for YTD 2021 and Q3 | Indicator | YTD (CNY) | YTD YoY (%) | Q3 (CNY) | Q3 YoY (%) | | :--- | :--- | :--- | :--- | :--- | | Operating Revenue | 832,643,423.75 | 20.20% | 283,542,552.49 | 8.51% | | Net Profit Attributable to Parent Company Shareholders | 94,499,159.16 | 29.34% | 33,158,153.77 | 13.94% | | Net Profit Attributable to Parent Company Shareholders (Excluding Non-Recurring Items) | 73,567,457.33 | 19.51% | 25,721,830.02 | -1.45% | | Net Cash Flow from Operating Activities | 74,026,476.09 | -10.50% | Not Applicable | Not Applicable | | Basic Earnings Per Share (CNY/share) | 0.39 | 14.71% | 0.13 | -7.14% | Key Balance Sheet Indicators at Period End | Indicator | As of 2021-09-30 (CNY) | Change from Prior Year-End (%) | | :--- | :--- | :--- | | Total Assets | 1,995,930,623.80 | 37.51% | | Total Equity Attributable to Parent Company Shareholders | 1,590,645,664.60 | 53.82% | Non-Recurring Gains and Losses In the first three quarters of 2021, total non-recurring gains and losses amounted to 20.93 million CNY, primarily from government grants Details of Non-Recurring Gains and Losses (YTD) | Item | Amount (CNY) | | :--- | :--- | | Government Grants Recognized in Current Profit/Loss | 24,658,773.33 | | Fair Value Change Gains/Losses on Financial Assets Held for Trading | 1,609,169.61 | | Gains/Losses on Disposal of Non-Current Assets | -23,441.56 | | Other Non-Operating Income and Expenses | 588,913.46 | | Total | 20,931,701.83 | Analysis of Key Financial Indicator Changes Significant increases in total assets and shareholder equity at period-end were primarily due to the company's non-public stock issuance - Total assets and equity attributable to parent company shareholders increased by 37.51% and 53.82% respectively from the beginning of the period, mainly due to the completion of a non-public stock issuance6 Shareholder Structure and Shareholding This section outlines the company's shareholder base, including the total number of shareholders and the concentrated holdings of its top investors Shareholding Status As of the report period end, the company had 15,284 common shareholders, with a concentrated ownership structure led by the largest shareholder and its parties acting in concert - As of the end of the reporting period, the company had 15,284 common shareholders8 Top Three Shareholders' Holdings | Shareholder Name | Number of Shares Held | Shareholding Percentage (%) | Shareholder Type | | :--- | :--- | :--- | :--- | | Qingdao Kangdien Industrial Co., Ltd. | 112,407,400 | 44.59 | Domestic Non-State-Owned Legal Person | | Tibet Sizhuang Investment Consulting Co., Ltd. | 17,775,520 | 7.05 | Domestic Non-State-Owned Legal Person | | Tibet Shancheng Investment Consulting Co., Ltd. | 17,775,520 | 7.05 | Domestic Non-State-Owned Legal Person | - Qingdao Kangdien Industrial Co., Ltd., Tibet Sizhuang Investment Consulting Co., Ltd., and Tibet Shancheng Investment Consulting Co., Ltd. constitute parties acting in concert8 Other Significant Matters This section highlights major capital market activities, including a non-public stock issuance and a stock option incentive plan Company's Major Operating Activities During the reporting period, the company completed a non-public stock issuance to raise capital and implemented a 2021 stock option incentive plan to motivate core employees - The company completed a non-public issuance of A-shares in April 2021, issuing 25,393,600 shares to Tibet Shancheng Investment Consulting Co., Ltd. and Tibet Sizhuang Investment Consulting Co., Ltd10 - In July 2021, the company granted 10 million stock options to 50 incentive recipients, completing the registration to align interests with core talent1113 Financial Statement Highlights This section presents key figures and trends from the consolidated balance sheet, income statement, and cash flow statement Consolidated Balance Sheet As of September 30, 2021, total assets reached 1.996 billion CNY, growing 37.51% from the year-start, with a robust financial structure and increased shareholder equity Key Items from Consolidated Balance Sheet (Unit: CNY) | Item | As of Sep 30, 2021 | As of Dec 31, 2020 | | :--- | :--- | :--- | | Total Assets | 1,995,930,623.80 | 1,451,467,768.17 | | Construction in Progress | 302,308,125.17 | 122,584,087.78 | | Financial Assets Held for Trading | 242,000,000.00 | 97,454,650.95 | | Total Liabilities | 320,085,237.93 | 336,219,746.02 | | Total Equity | 1,675,845,385.87 | 1,115,248,022.15 | | Capital Reserve | 708,952,817.36 | 308,358,239.28 | Consolidated Income Statement In the first three quarters of 2021, total operating revenue reached 833 million CNY, a 20.20% increase, with net profit attributable to parent company shareholders growing 29.34% Key Items from Consolidated Income Statement (Jan-Sep 2021 vs Jan-Sep 2020) | Item | Jan-Sep 2021 (CNY) | Jan-Sep 2020 (CNY) | YoY Change | | :--- | :--- | :--- | :--- | | Total Operating Revenue | 832,643,423.75 | 692,731,084.70 | +20.20% | | Operating Cost | 447,788,318.80 | 343,619,858.51 | +30.32% | | Research and Development Expenses | 74,139,432.07 | 58,320,394.34 | +27.12% | | Operating Profit | 120,825,946.72 | 101,504,945.70 | +19.04% | | Net Profit Attributable to Parent Company Shareholders | 94,499,159.16 | 73,060,721.43 | +29.34% | Consolidated Cash Flow Statement In the first three quarters of 2021, net cash from operating activities was 74.03 million CNY, while significant outflows from investing activities were offset by inflows from financing activities Key Items from Consolidated Cash Flow Statement (Jan-Sep 2021 vs Jan-Sep 2020) | Item | Jan-Sep 2021 (CNY) | Jan-Sep 2020 (CNY) | | :--- | :--- | :--- | | Net Cash Flow from Operating Activities | 74,026,476.09 | 82,706,547.97 | | Net Cash Flow from Investing Activities | -592,769,718.27 | -100,525,999.98 | | Net Cash Flow from Financing Activities | 439,140,534.17 | -4,268,786.76 | | Net Increase in Cash and Cash Equivalents | -79,602,708.01 | -22,088,238.77 | | Cash and Cash Equivalents at Period End | 170,286,888.15 | 151,903,416.00 |